Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-05-10 4:58 pm Unchanged | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 1,312,532 4.17% | 0 (Unchanged) | View |
| 2022-05-02 5:27 pm Unchanged | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 1,312,532 4.17% | 0 (Unchanged) | View |
| 2022-04-21 1:09 pm Unchanged | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 1,312,532 4.17% | 0 (Unchanged) | View |
| 2022-03-16 08:00 am Unchanged | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 1,312,532 4.18% | 0 (Unchanged) | View |
| 2022-03-07 3:53 pm Unchanged | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 1,312,532 4.18% | 0 (Unchanged) | View |
| 2022-03-04 5:23 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | LYTTON LAURENCE W | 1,864,115 5.9% | 1,747,115 (+1493.26%) | View |
| 2022-02-28 1:16 pm Purchase | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 1,312,532 4.18% | 71,700 (+5.78%) | View |
| 2022-02-22 7:04 pm Purchase | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 1,240,832 3.95% | 460,400 (+58.99%) | View |
| 2022-02-14 4:39 pm Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | ACUTA CAPITAL PARTNERS LLC | 0 0% | -1,357,500 (Position Closed) | View |
| 2022-02-14 08:05 am Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Nantahala Capital Management LLC | 2,761,660 8.8% | 896,326 (+48.05%) | View |
| 2022-02-11 5:55 pm Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | Stonepine Capital Management LLC | 0 0% | -2,144,812 (Position Closed) | View |
| 2022-02-11 4:18 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | ORBIMED ADVISORS LLC | 1,350,602 4.3% | 1,350,602 (New Position) | View |
| 2022-02-11 4:16 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | RENAISSANCE TECHNOLOGIES LLC | 1,771,908 5.64% | 1,572,910 (+790.41%) | View |
| 2022-01-27 11:56 am Unchanged | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 780,432 2.48% | 0 (Unchanged) | View |
| 2022-01-18 06:15 am Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | Assenagon Asset Management S.A. | 0 0% | -1,876,898 (Position Closed) | View |
| 2022-01-18 06:12 am Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Assenagon Asset Management S.A. | 1,876,898 5.98% | 762,294 (+68.39%) | View |
| 2022-01-05 5:29 pm Purchase | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 780,432 2.48% | 120,000 (+18.17%) | View |
| 2021-10-25 9:08 pm Purchase | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 660,432 2.11% | 261,594 (+65.59%) | View |
| 2021-02-18 7:48 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Stonepine Capital Management LLC | 2,144,812 6.9% | 1,310,363 (+157.03%) | View |
| 2021-02-16 06:14 am Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | ACUTA CAPITAL PARTNERS LLC | 1,357,500 6.1% | 1,357,500 (New Position) | View |